Adipocytic sclerostin loop3-LRP4 interaction required by sclerostin to impair whole-body lipid and glucose metabolism. [PDF]
Jiang H +28 more
europepmc +1 more source
Association Between Sclerostin and Sarcopenia-Related Functional Decline in Older Women. [PDF]
Lee DG, Lee JH, Kong E.
europepmc +1 more source
Sclerostin deficiency sensitizes white adipocytes to thermogenic signals that induce beiging in mice. [PDF]
Choquette GM +10 more
europepmc +1 more source
CIMT as a sensitive indicator of cardiovascular risk in PCOS: a case-control study of sortilin and sclerostin. [PDF]
Çalışkan Burgucu H +7 more
europepmc +1 more source
Increase in serum DKK1 levels attenuates the anabolic response to romosozumab in postmenopausal osteoporosis. [PDF]
Adami G +10 more
europepmc +1 more source
Assessing Bone and Adipose Tissue Biomarkers in 5-6-Year-Old Polish Children Adhering to Vegetarian and Traditional Diets. [PDF]
Ambroszkiewicz J +5 more
europepmc +1 more source
Intestinal Sclerostin Deficiency Links Gut Dysbiosis to Altered Serotonin Homeostasis in Axial Spondyloarthritis. [PDF]
Mauro D +20 more
europepmc +1 more source
Cerebrospinal fluid sclerostin levels in the early Alzheimer's disease stages. [PDF]
Dicarlo M +14 more
europepmc +1 more source
Assessment of the efficacy and safety of anti-sclerostin antibody therapy for osteoporosis in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials. [PDF]
Chen L, Wang Q, Gu M.
europepmc +1 more source
Early intermittent low-dose sclerostin antibody treatment promotes surface bone formation and reduces bone loss, but also decreases osteocyte apoptosis and mechanotransduction in ovariectomized rats: A pilot study. [PDF]
Naqvi SM +7 more
europepmc +1 more source

